Nkarta Therapeutics Competitors and Similar CompaniesClear all
Nkarta Therapeutics's competitors and similar companies include Lyell, Courier Therapeutics and OncoQR ML.
 Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. |  Courier Therapeutics Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform. | |||
Founding Date | Founding Date 2015 | Founding Date 2018 | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Houston, US HQ Houston, US | Locations Wien, AT HQ Irenental, AT Wien, AT |
Employees | Employees 1594% decrease | Employees 188 | Employees 1 | Employees 3 |
Valuation ($) | Valuation ($) 240.6 m | Valuation ($) 243.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($104.1m) (FY, 2025) | Net income ($274.4m) (FY, 2025) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companyCourier Therapeutics
HQ
Houston, US
Employees
1
Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.
View company
OncoQR ML
HQ
Wien, AT
Employees
3
OncoQR ML is a biotech company that develops cancer immunotherapies.
View company